Frias JP, Bastyr EJ, Vignati L, Tschp MH, Schmitt C, Owen K, et al
Despite their advantages, its essential to use semaglutide under careful supervision, considering potential side effects like gastrointestinal discomfort and rare but serious complications
In total, 12 trials from SMART-C were assessed, with the analysis cohort restricted to trials exclusively enrolling participants with diabetes, and participants with diabetes enrolled in the following heart failure and chronic kidney disease trials: DAPA-CKD, EMPA-KIDNEY, DAPA-HF, EMPEROR-Reduced, EMPEROR-Preserved, and DELIVER
For patients without insurance coverage, the calculation of whether to continue treatment includes both financial and health costs
These results suggest that GLP-1 receptor agonists may be useful in not only increasing lifespan, but also increasing healthspan
These diverse applications make BPC-157 Peptides a focal point in studies aimed at understanding their impact on overall physical resilience and mobility